Skip to main content
Clinical Trials/NL-OMON20387
NL-OMON20387
Recruiting
Not Applicable

Optical spectral transmission imaging for treatment monitoring and correlation with arterial stiffness in patients with rheumatoid artritis starting with TNF inhibiting therapy

Reade Center for Rehabilitation and Rheumatology0 sites40 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Rheumatoid arthritis,Cardiovascular disease
Sponsor
Reade Center for Rehabilitation and Rheumatology
Enrollment
40
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Sponsor
Reade Center for Rehabilitation and Rheumatology

Eligibility Criteria

Inclusion Criteria

  • 18 years or older
  • \- Active rheumatoid arthritis in hands or wrists, defined as ≥ 2 swollen hand joints (IP, PIPs and/or MCPs) or ≥ 1 swollen wrist joints

Exclusion Criteria

  • \- Surgery in wrist or hand in the preceding 3 months
  • \- Other active concomitant musculoskeletal disease

Outcomes

Primary Outcomes

Not specified

Similar Trials